What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Today's Stock Analyst Initiations and New Coverage

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ABCL AbCellera Biologics	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alice Nettleton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.64 +0.7%	$18.00	Buy
ABTC American Bitcoin	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.09 +4.7%	$22.00	Buy
AIIR AIR Global	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.51 +0.9%		Overweight
AMRZ Amrize	Initiated by	Longbow Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Macgregor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.06 -0.4%		Buy
APD Air Products and Chemicals	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$283.63 +0.8%		Overweight
AXGN AxoGen	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Travis Steed Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.11 +2.7%	$52.00	Buy
AXTA Axalta Coating Systems	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$33.05 +1.3%		Overweight
BBNX Beta Bionics	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Toomey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.86 +1.3%	$30.00	Buy
BFLY Butterfly Network	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Plovanic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.56 +3.8%	$10.00	Buy
BRO Brown & Brown	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Kligerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$63.69 +1.3%	$82.00	Buy
I have publicly predicted six major American crashes, before each one happened. (Ad) Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks. See Martin Weiss's full warning before this risk spreads further
CHMG Chemung Financial	Initiated by	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$80.90 +0.4%	$88.00	Market Perform
CNTB Connect Biopharma	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Will Soghikian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.91 +4.1%	$4.00	Outperform
COAG Hemab Therapeutics	Initiated by	Rodman & Renshaw Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael G. King Jr. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.39 -3.9%	$56.00	Buy
CRM Salesforce	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$233.74 +2.0%		Buy
CRM Salesforce	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$233.74 +2.0%		Buy
CRM Salesforce	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$233.74 +2.0%		Outperform
CRM Salesforce	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jackson Ader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$233.74 +2.0%		Sector Weight
ENTG Entegris	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$160.01 -3.5%		Overweight
EQ Equillium	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Will Soghikian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.50 +6.4%	$6.00	Outperform
ESI Element Solutions	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$36.42 +0.3%		Overweight
FTI TechnipFMC	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$69.74 +0.2%		Outperform ➝ Buy
HIG The Hartford Insurance Group	Initiated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Hughes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.08 +0.7%	$137.00	Hold
HOOD Robinhood Markets	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$109.22 +0.2%	$130.00	Outperform
IBKR Interactive Brokers Group	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$87.89 +0.0%	$100.00	Outperform
IBKR Interactive Brokers Group	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian B Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.89 +0.0%	$102.00	Buy
IDXX IDEXX Laboratories	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Dechert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$523.94 +1.1%		Sector Weight
KARD Kardigan	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alice Nettleton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.35 -2.2%	$25.00	Buy
LIN Linde	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$487.35 +0.7%		Overweight
LVS Las Vegas Sands	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Choi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.13 -0.1%	$71.50	Buy
MLCO Melco Resorts & Entertainment	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Choi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.22 -0.2%	$9.40	Buy
MMED MiniMed Group	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Toomey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.80 -4.6%	$22.00	Hold
MRAM Everspin Tech	Initiated by	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jack Vander Aarde Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.28 -7.1%	$25.00	Buy
NKTR Nektar Therapeutics	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Will Soghikian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.84 -3.2%	$130.00	Outperform
NKTR Nektar Therapeutics	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alice Nettleton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.84 -3.2%	$53.00	Overweight ➝ Neutral
ODTX Odyssey Therapeutics	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alice Nettleton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.26 -3.9%	$27.00	Buy
PTGX Protagonist Therapeutics	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alice Nettleton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$144.88 +0.8%	$184.00	Buy
Q Qnity Electronics	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$123.29 -2.6%		Overweight
QTTB Q32 Bio	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Will Soghikian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.74 +4.8%	$40.00	Outperform
SCHW Charles Schwab	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$97.08 +0.4%	$107.00	In-Line
SOLS Solstice Advanced Mat	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$60.71 -1.0%		Overweight
Urgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20th (Ad) Marc Chaikin, a 60-year Wall Street veteran whose past clients include George Soros and Steve Cohen, built a system that flagged Nvidia before it climbed more than 50,000%. Following Executive Order #14363, next-generation AI data centers are coming online, and Chaikin says one stock is leading this buildout. Get the stock name and ticker from Chaikin's research now.
THFF First Financial Corporation Indiana	Initiated by	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brendan Nosal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.63 +1.2%	$85.00	Outperform
VERA Vera Therapeutics	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Will Soghikian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.72 -7.2%	$34.00	Market Perform
VYLR Vylor	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucas Beaumont Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$75.47 +3.2%	$89.00	Buy
WLK Westlake	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$61.81 -0.8%		Overweight ➝ Underweight
WULF TeraWulf	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Elias Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.37 -2.9%	$21.00	Buy